Gaudium IVF promoters report no share encumbrance in FY26

1 min read     Updated on 18 Jun 2026, 02:27 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Gaudium IVF and Women Health Limited disclosed that its promoters and promoter group did not encumber any shares during the financial year ended March 31, 2026. The declaration was submitted to stock exchanges on April 06, 2026, in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing includes a list of 13 individuals and entities comprising the promoter and promoter group.

powered bylight_fuzz_icon
43275460

*this image is generated using AI for illustrative purposes only.

Gaudium IVF and Women Health Limited has disclosed that its promoters and promoter group have not created any encumbrance over the company's shares during the financial year ended March 31, 2026. This declaration, submitted to the stock exchanges on April 06, 2026, confirms that no shares held directly or indirectly by the promoters were pledged or otherwise encumbered in FY26.

The disclosure was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dr. Manika Khanna, a promoter of the company, confirmed that neither the promoters, the promoter group, nor any persons acting in concert had made any encumbrance over the shares during the specified period.

The filing identified the individuals and entities that constitute the promoter and promoter group. The list includes three promoters and ten members of the promoter group, comprising individuals and private limited companies associated with the founders.

Promoter and Promoter Group Details

The following table outlines the members of the promoter and promoter group as per the disclosure:

Sr. No. Name Category
1. Dr. Manika Khanna Promoter
2. Dr. Peeyush Khanna Promoter
3. Mr. Vishad Khanna Promoter
4. Dr. Gautam Anand Promoter Group
5. Dr. Rajinder Kumar Anand Promoter Group
6. Mrs. Malini Anand Promoter Group
7. Ms. Shobhini Khanna Promoter Group
8. Mrs. Sucharita Malhotra Promoter Group
9. Mrs. Ritambhara Dewan Promoter Group
10. M/s. EKK Hospitality Private Limited Promoter Group
11. M/s. EKK Global Private Limited Promoter Group
12. M/s. Gaudium Foundation Promoter Group
13. M/s. Gaudium Signature Lab Promoter Group

The document was signed by Naveen Kumar, Company Secretary and Compliance Officer of Gaudium IVF and Women Health Limited. The company requested the exchanges to place the information on record.

Historical Stock Returns for Gaudium IVF & Women Health

1 Day5 Days1 Month6 Months1 Year5 Years
+2.00%+7.04%+6.13%+35.46%+35.46%+35.46%

How will the zero-encumbrance status impact investor confidence and the company's ability to raise capital in the future?

What are the strategic growth plans for Gaudium IVF that might require the promoters to consider leveraging their shares in the coming years?

How does this clean shareholding structure position the company relative to competitors in the fertility and women's health sector?

Gaudium IVF & Women Health
View Company Insights
View All News
like20
dislike

Gaudium IVF and Women Health schedules analyst meet on June 12

0 min read     Updated on 09 Jun 2026, 01:33 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Gaudium IVF and Women Health Limited has scheduled a virtual analyst and institutional investor meet for June 12, 2026, from 11.00 AM to 12:00 PM. Organized by Choice Broking, the meeting will discuss publicly available information without sharing unpublished price sensitive data or making a presentation. The event is conducted under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

powered bylight_fuzz_icon
42479639

*this image is generated using AI for illustrative purposes only.

Gaudium IVF and Women Health Limited has scheduled an analyst and institutional investor meet for June 12, 2026, to engage with the investment community. The virtual meeting, organized by Choice Broking, will provide a platform for discussions based on publicly available information. No unpublished price sensitive information will be shared during the session, and no presentation is planned.

The meeting is scheduled to take place from 11.00 AM to 12:00 PM. The event is part of the company's ongoing investor relations activities conducted under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Schedule of Meeting

Name of Institutions/ Investor Meet Date of Analyst/ Institutional Investor Meet Time Nature of Meeting Organized By
InsightX Conference Friday, June 12, 2026 11.00 AM to 12:00 PM Virtual Meeting Choice Broking

The company noted that the schedule is subject to change due to exigencies. Further details and updates regarding the meeting will be available on the company's website.

Historical Stock Returns for Gaudium IVF & Women Health

1 Day5 Days1 Month6 Months1 Year5 Years
+2.00%+7.04%+6.13%+35.46%+35.46%+35.46%

What strategic priorities is Gaudium IVF likely to emphasize during the meeting to attract institutional investors?

How might the company's recent performance and future growth plans influence investor sentiment post-meeting?

Could this meeting signal potential upcoming partnerships or expansions in the women's health sector?

Gaudium IVF & Women Health
View Company Insights
View All News
like20
dislike

More News on Gaudium IVF & Women Health

1 Year Returns:+35.46%